Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/2014
03/05/2014CN103610658A Immunomodulator slow-release preparation and preparation method thereof
03/05/2014CN103610655A Roflumilast tablet composition
03/05/2014CN103610651A Lyophilized levofloxacin composition powder for injection
03/05/2014CN103610650A Isosorbide mononitrate sustained-release pallets, preparation prepared from same and preparation method for isosorbide mononitrate sustained-release pallets
03/05/2014CN103610649A Medicament microsphere and preparation method thereof
03/05/2014CN103610648A Preparation method of enrofloxacin composite sustained-release microspheres
03/05/2014CN103610647A Fenbendazole pellet pill
03/05/2014CN103610646A Composition containing everolimus and preparation method thereof, and pharmaceutical preparation containing composition
03/05/2014CN103610644A Preparation method of polymer nanoparticles capable of promoting epithelial cell drug delivery
03/05/2014CN103610640A Alprostadil medium-and-long-chain lipid emulsion for injection and preparation method thereof
03/05/2014CN103610639A Polymeric micelle medicine-loaded composition containing buffer salt and preparation method thereof
03/05/2014CN103610638A Large capacity zedoary turmeric oil injection liquid and preparation method thereof
03/05/2014CN103610637A Rifampicin injection and preparation method thereof
03/05/2014CN103610636A Medicinal composition containing epigallocatechin gallate and application of medicinal composition
03/05/2014CN103610053A High-purity grape seed extract tablet and preparation method thereof
03/05/2014CN102940885B Method for improving efficiency of meso-porous silicon nano materials entering into cells by utilizing cationic liposome
03/05/2014CN102895213B Stable cefotiam hexetil hydrochloride composition
03/05/2014CN102871956B Propranolol hydrochloride gel for treating infant superficial hemangioma
03/05/2014CN102813626B Amorphous form cefmenoxime hydrochloride compound combination for injection
03/05/2014CN102793925B Medicinal premixing agent consisting of hydroxypropyl cellulose and lactose
03/05/2014CN102698089B Preparation method of ephedrine extract-containing oral solution for preventing and treating cerebral ischemia
03/05/2014CN102697738B Preparation method of porous microspheres by carbon dioxide fluid anti-solvent method
03/05/2014CN102626441B Antipyrotic powder for external use
03/05/2014CN102580115B Tuberculosis mucosa gene vaccine assembled by using chitosan oligosaccharide delivery system and preparation and application of tuberculosis mucosa gene vaccine
03/05/2014CN102512684B Sustained release premixing agent
03/05/2014CN102448445B Orally disintegrating coated tablet
03/05/2014CN102432886B Preparation method of star-type polylactic-acid grafting sodium alginate particles
03/05/2014CN102300576B Treating idiopathic thrombocytopenic purpura with compositions comprising extracts of astragalus membranaceus
03/05/2014CN102178604B Device and method for preparing gel microsphere and gel microsphere in which antitubercular agents can be injected
03/05/2014CN102172262B Enzyme treatment for infection
03/05/2014CN102048688B Taxol submicroemulsion taking cholesterol complex as intermediate carrier
03/05/2014CN102048677B Valganciclovir Hydrochloride solid preparation and preparation method thereof
03/05/2014CN101969956B Corticosteroid compositions
03/05/2014CN101951762B Foam stabilizer composition
03/05/2014CN101795713B Conjugate purification
03/04/2014US8664382 Antibacterial compositions comprising metal phthalocyanine analogues
03/04/2014US8664224 External preparation for athlete's foot treatment
03/04/2014US8663703 Drug microparticles, processes of preparing them and a drug delivery vehicle comprising them
03/04/2014US8663700 Drug loaded polymeric nanoparticles and methods of making and using same
03/04/2014US8663693 Nanoparticulate formulations of fenofibrate
03/04/2014US8663684 Lactose and cellulose-based tableting aid
03/04/2014US8663679 Compositions for improving breast health in women
03/04/2014US8663678 Solid dosage form for the ocular administration of an active principle, a soluble, solid ophthalmic insert and the production method thereof
03/04/2014US8663677 Controlled release system and manufacturing method thereof
03/04/2014US8663660 Polymerized micelles
03/04/2014US8663658 Revaprazan-containing solid dispersion and process for the preparation thereof
03/04/2014US8663606 Method of producing a cationic liposomal preparation comprising a lipophilic compound
03/04/2014US8663603 Multivalent constructs for therapeutic and diagnostic applications
03/04/2014CA2737463C Freeze-dried powder preparation of tetrodotoxin and the producing method thereof
03/04/2014CA2675374C Formulations for parenteral administration of amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones
03/04/2014CA2565188C Compounds and compositions for delivering active agents
02/2014
02/27/2014WO2014032026A1 Ophthalmic formulation of polyoxyl lipid or polyoxyl fatty acid and treatment of ocular conditions
02/27/2014WO2014031958A1 Chemical compositions and methods for enhancing transdermal delivery of therapeutic agents
02/27/2014WO2014031861A1 Engineered anthrax lethal toxin for targeted delivery
02/27/2014WO2014031836A1 Managing weight loss and body mass
02/27/2014WO2014031600A1 Haptens of quetiapine for use in immunoassays
02/27/2014WO2014031595A1 Haptens of paliperidone
02/27/2014WO2014031587A1 Haptens of olanzipine
02/27/2014WO2014031584A1 Haptens of aripiprazole and their use in immunoassays
02/27/2014WO2014031566A1 Cytotoxic benzodiazepine derivatives
02/27/2014WO2014031476A1 Mesothelin domain-specific monoclonal antibodies and use thereof
02/27/2014WO2014031034A1 Pharmaceutical compositions containing ipidacrine and use thereof to treat potency disorders and other sexual activity disorders
02/27/2014WO2014030975A1 Method for manufacturing carbon nanotube-based anti-cancer agent suppressing cancer cell resistance
02/27/2014WO2014030974A1 Carbon nanotube-based anti-cancer agent suppressing cancer cell resistance
02/27/2014WO2014030913A1 Poly(4-hydroxybutyrate)-b-monomethoxy(polyethylene glycol) copolymer nanoparticles, production method for same and pharmaceutical composition for brain disorder treatment containing same as active ingredient
02/27/2014WO2014030728A1 Fcγriib-specific fc region variant
02/27/2014WO2014030715A1 Boron cluster-modified peg lipid derivative, and molecular assembly using same
02/27/2014WO2014030656A1 Medicament-containing hollow particle
02/27/2014WO2014030605A1 Nutritional composition
02/27/2014WO2014030204A1 Medicament-containing hollow particle
02/27/2014WO2014029984A1 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
02/27/2014WO2014029983A1 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
02/27/2014WO2014029780A1 Companion cosmetic compositions
02/27/2014WO2014029464A1 Solid pharmaceutical preparation containing levothyroxine
02/27/2014WO2014028999A1 Essential oil microparticles and uses thereof for preventing enteric diseases
02/27/2014WO2013178788A3 Manufacture of degarelix
02/27/2014WO2013178627A3 Protein assembler
02/27/2014WO2013171661A3 Adjuvant formulations and methods
02/27/2014WO2013142611A3 Silk reservoirs for drug delivery
02/27/2014US20140058067 Immunoconjugates with an Intracellularly-Cleavable Linkage
02/27/2014US20140058064 Multi-drug ligand conjugates
02/27/2014US20140058063 Vitamin receptor binding drug delivery conjugates
02/27/2014US20140057999 Protective, hydrocolloid for active ingredients
02/27/2014US20140057996 Method for preparing silica compositions, silica compositions and uses thereof
02/27/2014US20140057956 Copolymerised fatty body, preparation method thereof and uses of same
02/27/2014US20140057875 Crystallization method and bioavailability
02/27/2014US20140057856 Compositions and Methods For Enhancing Sialic Acid Levels In Tissue
02/27/2014US20140057855 Cyclosporin compositions
02/27/2014US20140057854 Topical formulations and uses thereof
02/27/2014US20140057828 Small Peptide Modulators of Potassium Channel Trafficking
02/27/2014US20140056997 Use of low molecular weight amino alcohols in ophthalmic compositions
02/27/2014US20140056980 Delayed release drug formulation
02/27/2014US20140056977 Solid pharmaceutical composition containing 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta (c)chromen-3-yl sulfamate and polymorphs thereof
02/27/2014US20140056974 Spontaneously Dispersible N-Benzoyl Staurosporine Compositions
02/27/2014US20140056972 Anti-dclk1 monoclonal antibodies and methods of production and use thereof
02/27/2014US20140056966 Conjugate angiostation or its fragment, the method of producing the conjugate and use thereof
02/27/2014US20140056963 Extended production of nitric oxide from a microencapsulated nitrite salt and an aqueous acidified gel
02/27/2014US20140056953 Fatty acid acylated amino acids for oral peptide delivery
02/27/2014US20140056949 Controlled Release Mucoadhesive Systems
02/27/2014US20140056942 Liquid stable virus vaccines
1 ... 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 ... 1712